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Theophylline inhibits the cough reflex through a novel
mechanism of action
Eric Dubuis, PhD, Michael A. Wortley, BSc, Megan S. Grace, PhD, Sarah A. Maher, PhD, John J. Adcock, PhD,
Mark A. Birrell, PhD, and Maria G. Belvisi, PhD London, United KingdomBackground: Theophylline has been used in the treatment of
asthma and chronic obstructive pulmonary disease formore than
80 years. In addition to bronchodilator and anti-inflammatory
activity, clinical studies have suggested that theophylline acts as
an antitussive agent. Cough is the most frequent reason for
consultation with a family doctor, and treatment options are
limited. Determining how theophylline inhibits cough might lead
to the development of optimized compounds.
Objective: We sought to investigate the inhibitory activity of
theophylline on vagal sensory nerve activity and the cough reflex.
Methods: Using a range of techniques, we investigated the effect
of theophylline on human and guinea pig vagal sensory nerve
activity in vitro and on the cough reflex in guinea pig challenge
models.
Results: Theophylline was antitussive in a guinea pig model,
inhibited activation of single C-fiber afferents in vivo and
depolarization of human and guinea pig vagus in vitro, and
inhibited calcium influx in airway-specific neurons in vitro.
A sequence of pharmacological studies on the isolated vagus and
patch clamp and single-channel inside-out experiments showed
that the effect of theophylline was due to an increase in the open
probability of calcium-activated potassium channels. Finally, we
demonstrated the antitussive activity of theophylline in a
cigarette smoke exposure model that exhibited enhanced tussive
responses to capsaicin.
Conclusion: Theophylline inhibits capsaicin-induced cough
under both normal and ‘‘disease’’ conditions by decreasing the
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Open access under CC BY license.intermediate-conductance calcium-activated potassium
channels. These findings could lead to the development of
optimized antitussive compounds with a reduced side effect
potential. (J Allergy Clin Immunol 2014;133:1588-98.)
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Theophylline has been used in the treatment of respiratory
diseases, such as asthma and chronic obstructive pulmonary
disease (COPD), for more than 80 years. Although in
industrialized countries b-agonists and steroids are the preferred
treatment, globally, theophylline remains a widely prescribed
drug, particularly in patients with more severe disease, because it
is cheap and readily available.1 Although it has been primarily
prescribed for its bronchodilator activity, there is a large body
of evidence suggesting that it also possesses anti-inflammatory
activity in both asthmatic patients and patients with COPD.2-4
Furthermore, clinical studies have shown that adding theophyl-
line to inhaled steroids in patients with mild-to-moderate asthma
and to long-actingb-adrenoceptor agonists in patients with severe
COPD provides additional clinical improvement. In addition to
these properties, preclinical and clinical studies have suggested
that both theophylline and another methylxanthine, theobromine,
act as antitussive agents in several preclinical studies and in
patients with a range of clinical conditions.5,6 In children and
adults with poorly controlled asthma, theophylline significantly
improved symptom scores for cough and wheeze compared
with placebo.7 Theophylline has also been recommended for
the treatment of cough in patients with COPD8 and has been
shown to be effective for treating angiotensin-converting enzyme
inhibitor–related cough.9
Cough is a protective reflex and defense mechanism in healthy
subjects.10 However, cough is also the most common respiratory
complaint for which medical attention is sought,11 often presents
as the first and most persistent symptom of many respiratory
diseases, and can be idiopathic in nature.12 Chronic persistent
cough has a profoundly detrimental and debilitating effect on
quality of life that can lead to social isolation and clinical
depression.13 Cough is a major problem that leads patients to
use over-the-counter remedies as first-line treatments; United
Kingdom sales were greater than £350 million in 2004, and
US sales were greater than $2 billion.14 However, a recent
meta-analysis established that there was no good evidence for
the effectiveness of such remedies.15 Therefore the mechanisms
underlying chronic cough and the identification of novel
therapeutic targets for its treatment present a grossly neglected
and unmet clinical need.
In this study we have demonstrated that theophylline inhibits
sensory nerve activation and the cough reflex and uncovered a
possible mechanism of action. This study highlights a previously
unrecognized benefit of theophylline that could explain the
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Elucidating the mechanism of action could lead to the develop-
ment of optimized compounds with a reduced side effect profile.METHODS
For a more detailed discussion of the methods used in this study, please see
the Methods section in this article’s Online Repository at www.jacionline.org.Animals
Male guinea pigs (Dunkin-Hartley, Harlan, United Kingdom) weighing
350 to 450 g (400-750 g for single-fiber in vivo studies) were housed in
temperature-controlled (218C) facilities with food and water ad libitum for
at least 1 week before the experiment. All experiments were performed in
accordance with the UK Home Office guidelines for animal welfare based
on the Animals (Scientific Procedures) Act of 1986.Effect of theophylline on citric acid–and
capsaicin-evoked cough in conscious guinea pigs
Conscious unrestrained guinea pigs were placed in individual plastic,
transparent, whole-body plethysmograph chambers, and cough was detected,
as previously described.16,17Effect of theophylline on capsaicin-induced firing of
single-fiber afferents and bronchospasm in vivo
Guinea pigs were anaesthetized with urethane (1.5 g/kg) intraperitoneally.
The trachea was cannulated, and pressure was measured with an air pressure
transducer connected to a side arm of the tracheal cannula. Animals
were paralyzed with vecuronium bromide, initially administered at a dose
of 0.10 mg/kg intravenously, followed every 20 minutes with 0.05 mg/kg
administered intravenously to maintain paralysis. Firing of single-fiber
afferents and bronchospasm was measured, as previously described.18Effect of theophylline on depolarization of the
vagus nerve preparation to various tussive agents
Guinea pigs were culled with an overdose of pentobarbitone (200 mg/kg
administered intraperitoneally). The 2 vagus trunks were carefully dissected
free and placed inKrebs–Henseleit solution. Segments of the vagus nervewere
mounted in a ‘‘grease-gap’’ dual recording chamber system, as previously
described.19,20Primary culture of sensory neurons
Calcium imaging of primary sensory jugular ganglia was performed,
as previously described.21 Identification of airway sensory neurons wasdone by means of intratracheal administration of the retrograde neuronal
tracer DilC18(3)-(1,19-dioctacetyl-3,3,39,39-tetramethyl-indocarbocyanine
perchlorate) (DiI; Invitrogen, Carlsbad, Calif) 2 weeks before collecting
the ganglia and isolating the cells. Camptothecin was used to inhibit
mitotic cell growth during the primary culture of neurons, and airway
neuron staining with DiI was assessed with 531/40 nm and 593/40 nm
excitation/emission filters (BS 565) before experimentation. Intracellular
calcium [Ca21]i and membrane voltage changes were simultaneously
optically measured in primary cultured dissociated jugular neurons
(see the Methods section in this article’s Online Repository). The
effect of theophylline on small-conductance calcium-activated potassium
channel (SK channel) and intermediate-conductance calcium-activated
potassium channel (IK channel) currents and analysis of the direct effect
of theophylline on calcium-activated potassium channels in the jugular
ganglia were also investigated (see the Methods section in this article’s
Online Repository).Cigarette smoke exposures
Guinea pigs were exposed to cigarette smoke from research cigarettes
(3R4F, with filters removed; University of Kentucky, Lexington, Ky) for
1 hour twice daily, with 4 hours between each bidaily exposure period.
Cigarette smoke exposure protocols are described in the Methods section in
this article’s Online Repository and were similar to those described by
Eltom et al.22Drugs and solutions
All compounds and drugs used are described in the Methods section in this
article’s Online Repository. The amount of vehicle (dimethyl sulfoxide) was
limited to 0.1% to avoid possible side effects, and the effect of theophylline
at each concentration was obtained in the presence of the same amount of
vehicle each time. In all the experimental design paradigms, the effect of
vehicle alone was assessed, and no significant effect observed.RESULTS
Effect of theophylline in a conscious guinea pig
cough model
Theophylline (1 hour before treatment) decreased the
number of coughs induced by aerosolized capsaicin (60 mmol/L,
n 5 15; Fig 1, A) and citric acid (300 mmol/L, n 5 12-15;
Fig 1, B).Effect of theophylline on C-fiber activation by
capsaicin in vivo
Capsaicin, when nebulized into the lungs of anaesthetized
guinea pigs, induced a burst of vagal C-fiber firing that was
significantly reduced by theophylline (Fig 2, A-C). Theophylline
administration per se did not modify the spontaneous firing
observed in the vagal C-fibers (Fig 2, C). Capsaicin also induced
a prolonged bronchoconstriction (which followed the C-fiber
firing) that was almost entirely abolished in the presence of
theophylline (Fig 2, A, D, and E). The possibility exists that
some of the C-fiber firing could be induced indirectly after the
bronchoconstrictor response elicited by capsaicin and that
theophylline is merely acting as a bronchodilator. Aerosolized
prostaglandin E2 (PGE2) was also used to induce bursts of C-fiber
firing to address this concern. Action potential trains were
obtained that were, on average, similar in total duration to
capsaicin and were not associated with any bronchoconstriction
(Fig 2, F, top panel). Theophylline significantly decreased
PGE2-induced firing (Fig 2, F, bottom panel).
FIG 1. Effect of theophylline on induced cough in a conscious guinea pig
model. The effect of theophylline on the number of coughs induced
by nebulized solutions of capsaicin (5 minutes, n 5 15; A) or citric acid
(10 minutes, n 5 12-15; B) into the plethysmograph recording chamber
and recorded over 10 minutes from the start of nebulization is shown.
The vehicle (Veh; 0.5%methylcellulose and 0.2% Tween 80 in saline admin-
istered intraperitoneally) or theophylline (administered intraperitoneally)
dose 1 hour before cough challenge is indicated. Data are presented as
means 6 SEs. **P < .01 and ***P < .001 using 1-way ANOVA with the
Dunnett multiple comparison post hoc test.
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excitation
Theophylline inhibited capsaicin-induced depolarization of
the guinea pig vagus axon in a concentration-dependent fashion
(Fig 3, A and B). A submaximal concentration of theophylline (10
mmol/L) similarly inhibited depolarization to a range of sensory
nerve stimulants, concentrations of which were selected from pre-
vious studies: capsaicin (1 mmol/L), PGE2 (10 mmol/L),
17,19
acrolein (300 mmol/L),16 bradykinin (3 mmol/L),21 resinifera-
toxin (3 nmol/),16 and low pH (pH 5)16 (Fig 3, C).Effect of potassium channel blockers on the
inhibitory effect of theophylline on capsaicin-
induced depolarization of guinea pig vagus
The general inhibitory effect of theophylline suggested that,
rather than blocking a specific receptor, it could activate a
mechanism that combats the depolarization of the neuronal
membrane by decreasing its excitability. Using pharmacological
agents at previously determined concentrations,23 we investigated
the role of potassium channels on the inhibitory effect of
theophylline. Preincubation with paxilline (a large-conductance
calcium-activated potassium channel [BKCa channel] blocker)
or glibenclamide (an ATP-sensitive potassium channel [KATPchannel] blocker) did not modify the inhibitory effect of theoph-
ylline on capsaicin (1 mmol/L)–induced depolarization of the va-
gus. In contrast, apamin (a highly selective SK1, SK2, and SK3
channel blocker) and clotrimazole (a selective IK blocker) signif-
icantly decreased the inhibitory effect of theophylline (Fig 4, A).
We reproduced the inhibitory effect observed with theophylline
using NS309 (an SK channel opener), and this inhibition was
significantly reduced in the presence of UCL1684 (10 mmol/L;
an SK channel blocker; Fig 4, C).Effect of theophylline on human vagal sensory
nerve activation
Theophylline significantly inhibited capsaicin-induced depo-
larization, an effect that was blocked in the presence of apamin
but not clotrimazole (in contrast to the data generated in guinea
pig vagus; Fig 4, D and E).Effect of theophylline on capsaicin-induced changes
in [Ca21]i levels and membrane voltage in primary
guinea pig sensory jugular neurons
The free resting calcium level was calculated under our
experimental conditions to be between 60 and 132 nmol/L
(average, 122 6 28 nmol/L; n 5 5) at rest in primary cultured
jugular neurons. This is lower than the estimated median effective
concentration of calmodulin (an SK channel calcium sensor) for
calcium (approximately 300-500 nmol/L) and suggests that the
SK channel will not be activated under basal conditions.
Capsaicin (1 mmol/L) in extracellular solution (ECS) was applied
through a fast perfusion for 30 seconds, and the response
was recorded until the signal returned to baseline. Theophylline
produced a concentration-dependent inhibition of capsaicin-
induced [Ca21]i increase and membrane depolarization (Fig 5,
A). From these experiments, a working concentration of
theophylline (0.1 mmol/L) was chosen as an approximate median
effective concentration (an effective concentration that blocks
50% of the maximal response) for future studies. Theophylline
also inhibited capsaicin-induced excitation of airway sensory
neurons originating from the jugular ganglion (Fig 5, B). The
inhibition achieved was similar to the inhibition obtained on
the response of all neurons (both airway-specific and nonairway
neurons).Effect of theophylline on SK and IK channel
potassium currents in the jugular ganglia and
analysis of the direct effect of theophylline on
calcium-activated potassium channels
The effect of theophylline on the restingmembrane potential of
primary jugular neurons was investigated with a patch clamp.
A perforated patch configuration was used to preserve the
intracellular content and [Ca21]i levels, and the cells were
constantly perfused with ECS at 378C. Theophylline significantly
hyperpolarized the membrane (Fig 6, A). Because the SK and IK
channel blockers apamin and clotrimazole blocked the inhibitory
effect of theophylline on vagus nerve activation, we investigated
the effect of theophylline on these currents. However, before
recording the potassium currents, the cell perfusion was switched
to calcium-free modified ECS to prevent calcium entry into
the cell during depolarization and to maintain the [Ca21]i
FIG 2. Effect of theophylline on airway vagal sensory afferent nerve firing and bronchospasm. A, Firing of a
single vagal C-fiber (top trace) and simultaneous airway/tracheal pressure change (bottom trace). Capsaicin
(100 mmol/L aerosol for 15 seconds, solid triangles), saline (Sal; 10 mL/kg, open triangles), or theophylline
(100 mg/kg administered intravenously) was administered as indicated. B-E, Histograms representing the
average total impulse count over time (5-minute window from nebulization) recorded from single vagal
C-fibers or average changes in airway/tracheal pressure in response to capsaicin in the presence of saline
(Fig 2, B and D) or theophylline (Fig 2, C and E), respectively. Data are expressed as means 6 SEs. P < .05
after analysis with the paired t test (n 5 3). F, Example recording of the effect of theophylline on PGE2
(100 mg/mL, aerosol for 1 minutes)–induced changes in airway/tracheal pressure change (top trace) and
simultaneous vagus nerve single C-fiber firing (bottom trace).
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back to ECS (calcium, 2.5 mmol/L) for all washout periods to
prevent the cells from depleting their calcium stores. Sodium
and calcium currents were blocked with nifedipine, tetrodotoxin,
and salt substitution with choline. We used recording subtraction
to isolate the potassium current generated by the SK and IKpopulations of channels: recordings made in the presence of
clotrimazole (10 mmol/L, a selective IK channel blocker) or
apamin (1 mmol/L, a selective SK1, SK2, and SK3 blocker) in
modified ECS were subtracted from their respective control
recordings also done in modified ECS to obtain the clotrimazole-
or apamin-sensitive currents (ie, the portion of the whole
FIG 3. Effect of theophylline on vagus nerve depolarization. A, Effect of
theophylline or vehicle (0.1% dimethyl sulfoxide, white bar) on capsaicin
(1 mmol/L)–induced depolarization of the guinea pig vagus nerve
(n 5 6-13). The gray bar indicates the working concentration chosen for
further experiments. *P < .05 and ***P < .001 using 1-way ANOVA with
the Dunnett multiple comparison post hoc test. B and C, Representative
trace (Fig 3, B) and box-and-whiskers diagram (Fig 3, C) showing the
percentage inhibition of TRPA1 and TRPV1 agonist–induced vagal
depolarization induced by theophylline (10 mmol/L, n 5 4-6 per agonist)
in which the middle line of the box indicates the median, the lower line
indicates the minimum, and the upper line indicates the maximum.
Whiskers indicate the 25th and 75th percentiles. Selected agonists were
capsaicin (Cap; 1 mmol/L), acrolein (Acro; 300 mmol/L), resiniferatoxin
(RTX; 3 nmol/L), acidity (pH 5, low pH), PGE2 (10 mmol/L), and bradykinin
(BK; 3 mmol/L).
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(left panel), shows clotrimazole-sensitive currents obtained in
control conditions (modified ECS 1 vehicle 2 theophylline
free) and after incubation with theophylline (0.1 mmol/L) in
modified ECS. The current density-voltage relationship displayed
in the right panel indicates that the clotrimazole-sensitive current
(IK) was significantly increased after incubation with theophyl-
line (0.1 mmol/L) at resting calcium levels (n 5 4). However,
the difference between the 2 curves only reached significance
(P <.05) when the potential reached160 mV with a 56% current
density increase from 0.256 0.04 pA/pF up to 0.396 0.05 pA/pF
at160 mV (n5 4). The apamin-sensitive current (Fig 6, C) was
also significantly increased after incubation with theophylline
(0.1 mmol/L) at resting calcium levels (n 5 4). The difference
between the 2 current-voltage curves reached significance for amembrane potential of 230 mV (P < .05), with a 105% current
density increase from 1.06 6 0.10 pA/pF up to 2.17 6 0.21 pA/
pF at 230 mV (n 5 4).
In single-channel inside-out experiments an excised patch
of membrane was successively exposed to control solutions
containing vehicle and supplemented with high and low
free calcium concentrations. The patch was then exposed to
theophylline (0.1 mmol/L) in solutions containing high and low
calcium concentrations to compare the open probability of the
same patch in all 4 conditions. Fig 7, A, shows the opening of the
channels from a patch of membrane with or without theophylline
in the bath. The theophylline effect appeared to be calcium
dependent because it did not induce any further channel opening
in low calcium. Unitary current was not changed after theophyl-
line application (0.97 6 0.16 pA in control vs 1.01 6 0.17 pA
in the presence of theophylline, n 5 5), whereas the channel
open probability increased by 62% 6 7% at 2100 mV voltage
in the presence of 500 nmol/L free calcium (Fig 7, B).Effect of theophylline on enhanced cough caused
by capsaicin
In this model exposure to cigarette smoke significantly
enhanced cough induced by capsaicin (Fig 8). Pretreatment
with theophylline almost abolished this enhanced cough.DISCUSSION
Theophylline has been used in the treatment of asthma and
COPD for many years and is still prescribed for its bronchodilator
activity and low cost.1 However, the need for therapeutic drug
monitoring and the hesitancy of clinicians to use theophylline
because of a perceived poor side effect profile has resulted in
the drug not being widely used. In the developed world it is
more commonly used as a third-line treatment, particularly in
patients with poorly controlled disease.1 Despite current COPD
guidelines indicating that theophylline is of limited value in the
routine management of COPD, many controlled clinical trials
support its utility in patients with stable COPD24,25 and also
observed worsening of the clinical state when theophylline was
withdrawn. Furthermore, it has also been recommended for the
treatment of cough in patients with COPD.8,26 In children and
adults with poorly controlled asthma, theophylline significantly
improved symptom scores for cough and wheeze compared
with placebo,7 and it has been shown to be effective for treating
angiotensin-converting enzyme inhibitor–related cough.9
The antitussive activity of another methylxanthine, theobro-
mine, has also been demonstrated in preclinical and clinical
studies.5,6 However, in previous studies it was suggested that this
property was particular to theobromine and not related to its
methylxanthine activity.27,28 However, the data presented
suggest that theophylline might present a readily available and
inexpensive alternative therapy to opioids for the treatment of
cough, which might be better tolerated and could be prescribed
for chronic cough throughout the developing and developed
world. The aim of these studies was to test the hypothesis that
theophylline possesses general antitussive activity by inhibiting
sensory nerve activity, thus highlighting a new application for
an old drug and potentially identifying a novel antitussive
mechanism that can be targeted by new therapeutic agents with
a more optimal therapeutic ratio.
FIG 4. Inhibition of the effect of theophylline on guinea pig vagus sensory nerve depolarization.
A, Theophylline inhibition of capsaicin (1 mmol/L)–induced depolarization in the presence of various ion
channel blockers: paxalline (BKCa channel, n 5 5), apamin (SK channel, n 5 5), clotrimazole (IK channel,
n5 4), glibenclamide (KATP channel, n5 5), and vehicle (0.1% dimethyl sulfoxide, n5 7). Data are expressed
as means 6 SEs. *P < .05 and **P < .01 using 1-way ANOVA with the Bonferroni multiple comparison post
hoc test. B, Inhibitory effect of NS309 (SK channel opener) on capsaicin-induced depolarization (n 5 4-6). C,
Point and line graphs showing the inhibition of capsaicin-induced depolarization by NS309 (30 mmol/L; left
panel, n 5 4) and the reversal induced by preincubation with the SK blocker UCL1684 (10 mmol/L; right
panel, n 5 3). D, Representative traces showing responses to capsaicin (1 mmol/L, solid triangles) recorded
by using human vagus nerve before and after incubation with theophylline (10 mmol/L) in the presence
of vehicle (0.1% dimethyl sulfoxide, top trace) or the SK channel blocker apamin (1 mmol/L, bottom trace,
n 5 4). E, Effect of vehicle, apamin, or clotrimazole on theophylline-induced inhibition of capsaicin-
induced depolarization of human vagus nerve (n 5 4). Data are expressed as means 6 SEs. *P < .05 after
analysis with the paired t test.
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FIG 5. Inhibition of capsaicin-induced activation of vagal sensory ganglia. A, Concentration-related
inhibitory effect of theophylline on capsaicin (1 mmol/L)–induced [Ca21]i signal (left panel) and membrane
depolarization (right panel) of jugular sensory neurons (n 5 10-22 per concentration; N 5 4 animals). Data
are presented as means 6 SEs. *P < .05 and ***P < .001 using 1-way ANOVA with the Bonferroni multiple
comparison post hoc test. B, Left panel, The top image shows primary cultured neurons dissociated from
jugular sensory neurons in bright field (open triangles). Of these 5 neurons, only 1 neuron stained with
retrograde tracer DiI originated from the airway (bottom image, indicated by white arrow). Top right panel,
Trace (F340/F380 ratio, vertical left scale) showing [Ca
21]i levels recorded with Fura2 for the airway neuron
exposed to potassium solution (K50; KCl 50 mmol/L) and then capsaicin (solid triangles) before and after
incubation with theophylline. Lower right panel, Histogram showing inhibition of capsaicin-induced
[Ca21]i signal and membrane depolarization by theophylline in sensory neurons (N 5 4 animals; n 5 6
airway and n 5 15 nonairway). Data are presented as means 6 SEs.
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demonstrated in a conscious guinea pig cough model against both
capsaicin and citric acid challenge, which are commonly used
tussive stimuli in human challenge studies.29 This is consistent
with a previous study that found significant inhibition of citricacid–induced cough using theophylline at 10 mg/kg.5 To confirm
an inhibitory effect on airway vagal afferents, we demonstrated an
effect of theophylline on capsaicin-induced excitation of airway
sensory neurons originating from the jugular ganglion. Further-
more, single-fiber recording studies demonstrated an inhibitory
FIG 6. Theophylline hyperpolarizes neurons by potentiating calcium-activated potassium currents. A, Left
panel, Box-and-whisker graph showing the range of membrane potentials at rest. Middle panel, Trace of
membrane potential change recorded during incubation with vehicle or theophylline in current clamp
mode (I 5 0) and perforated patch whole-cell configuration. Right panel, histogram of the averaged resting
membrane potential change recorded on 4 cells. Data are expressed as means 6 SEs. *P < .05 compared
with the control (vehicle, 0.1% dimethyl sulfoxide) using the Mann-WhitneyU test. B, Currents were elicited
by 800-ms square depolarizing pulses from 2100 mV up to 1120 mV with a 10-mV increment and 270 mV
holding potential. The zero current levels are indicated by an arrow on the left of the traces. Left panel,
Clotrimazole (10 mmol/L)–sensitive current obtained under control (0.1% dimethyl sulfoxide) conditions
and after incubation with theophylline. Right panel, Current density-voltage relationships in the control
condition (open circles, n 5 4) and after incubation with theophylline (0.1 mmol/L, solid circles, n 5 4).
*P < .05. C, Left panel, Apamin (1 mmol/L) sensitive current obtained control condition (0.1% dimethyl
sulfoxide) and after incubation with theophylline. Right panel, Current density-voltage relationships under
control conditions (open circles, n 5 4) and after incubation with theophylline (0.1 mmol/L, solid circles,
n 5 4). Data are expressed as means 6 SEs. Current density amplitudes were compared by using 2-way
ANOVA and Bonferroni post hoc tests. *P < .05.
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generation in C-fiber afferents. The inhibitory activity on
capsaicin-sensitive C-fibers was also accompanied by aninhibition of capsaicin-induced bronchospasm, confirming the
bronchodilator activity of theophylline at a similar dose range.
Antitussive activity of compounds, such as b2-adrenoceptor
FIG 7. Theophylline directly activates the SK channel independently from intracellular machinery.
Application of theophylline increases the open probability of SK channels in the presence of calcium.
A, Traces acquired at 2100 mV of channel openings recorded from the same patch of membrane in the
presence of the control (0.1% dimethyl sulfoxide, top panel) and in the presence of theophylline
(bottom panel)with high or low free calcium levels ([Ca21]i). The channel closed state (i5 0 pA) is indicated
on the right by a solid triangle. Open states are indicated with a bracket on the left and identified by a dotted
line. Current and time scales are indicated between both panels by black bars. B, Normalized amplitude
histograms of the single-channel traces from the patch displayed in Fig 7, A, recorded at high calcium levels
over 30 seconds and fitted by using a Gaussian function. The current level corresponding to the closed state
of the channel (0 pA) is indicated by a solid triangle. The amplitude scale is indicated below the histograms
on the x-axis.
FIG 8. Theophylline inhibits cigarette smoke–enhanced capsaicin-evoked
cough. Histograms showing cough counts per 10 minutes in response to
nebulized capsaicin (30 mmol/L for 5 minutes) for air-exposed (white bar) or
smoke-exposed (black bars) animals. Data are expressed as means6 SEMs
(n5 12). **P < .01 when comparing the response of air-exposed and smoke-
exposed animals to capsaicin. P < .001 when comparing smoke-exposed
animals’ response to capsaicin after treatment with theophylline
(100 mg/kg administered intraperitoneally 1 hour before the experiment)
or vehicle alone (0.5% methylcellulose and 0.2% Tween 80 in saline).
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activity.30 Aerosolized PGE2 was also used to induce bursts of
C-fiber firing to validate our hypothesis that theophylline has a
direct inhibitory effect on C-fiber afferents in vivo, rather than
acting simply as a bronchodilator. Theophylline inhibited the
action potential trains obtained to aerosolized PGE2, an agent
that activates C-fibers without evoking bronchoconstriction.
In further experiments to circumvent the potentially con-
founding bronchodilator properties of theophylline and toexplore its pharmacology in more detail, an isolated vagus
nerve preparation was used to study its effects directly on
sensory nerve depolarization, which is a measure of sensory
nerve activity.20,31 This technique has previously been charac-
terized, and the vagus axon has been shown to respond to a
range of agents known to cause cough both in preclinical
models and human cough studies. Furthermore, it provides the
opportunity to conduct a comprehensive pharmacologic assess-
ment of the direct action of drugs on the vagus without the phar-
macokinetic and numerous other considerations that limit the
interpretation of in vivo data. Although there are certain caveats
to using this technique, which have been extensively discussed
in other publications,19 it appears that responses in guinea pig
and human tissues are comparable and that the results translate
to in vivo models, suggesting that this technique is amenable for
use in studying the mechanisms involved in sensory nerve mod-
ulation.16,17,21 Theophylline inhibited capsaicin-induced depo-
larization of both guinea pig and human isolated vagus nerve
preparations. These data and the in vivo single-fiber recording
studies would suggest that the antitussive effect of theophylline
is due to a peripheral action on airway vagal sensory nerve
activity and not its bronchodilator activity.
Even in its recognized clinical role as a bronchodilator, the
underlying mechanism of action of theophylline is unclear.
However, it is known that theophylline is a weak and nonselective
phosphodiesterase (PDE) inhibitor that breaks down cyclic
nucleotides in the cell, leading to an increase in cyclic AMP
and cyclic GMP concentrations. Furthermore, there have been
some reports suggesting that certain PDE4 inhibitors can inhibit
cough to inhaled capsaicin in normal guinea pigs32,33 and in
allergic guinea pigmodels of asthma.32,34-36 However, in contrast,
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normal guinea pigs has also been reported.35 It is unlikely that
PDE inhibition can account for the inhibitory effect of theophyl-
line on sensory nerve depolarization and thereby its antitussive
activity, given that theophylline is reported to inhibit PDE1,
PDE2, PDE3, PDE4, and PDE5 with inhibitory concentration
of 50% (IC50’s) values of 280, 55, 98, 100 and 630 mmol/L in
human cell–based assay systems,37-39 whereas theophylline in-
hibited vagal sensory nerve depolarization in this study with an
approximate IC50 of 3 mmol/L. However, an in vivo inhibitory ef-
fect of theophylline on PDE4 activity cannot be completely ruled
out with regard to its in vivo antitussive activity. At therapeutic
concentrations, theophylline can also act as an antagonist of aden-
osine A1, A2, and A3 receptors. Furthermore, adenosine has been
shown to activate sensory afferents through A1 and A2a recep-
tors.40 However, we have established that theophylline inhibits
depolarization to a variety of tussive agents, including transient
receptor potential (TRP) V1 agonists (capsaicin and resinifera-
toxin), TRPA1 ligands (acrolein), PGE2, bradykinin, and low
pH, suggesting that theophylline acts as a general inhibitor of
neuronal excitability rather than an adenosine receptor
antagonist.
This study shows that theophylline decreases the excitability of
sensory nerves and thereby induced cough. Further investigation of
themechanism of action using the isolated vagus nerve preparation
and a pharmacological approach demonstrated it to be an activator
of calcium-activated potassium channels, which are involved in the
control of many neuronal processes, including regulation of the
firing rate along axons.41We showed the effect of theophyllinewas
due to activation of apamin-sensitive SK channels (SK1, SK2, and
SK3) and, to a lesser extent, IK channels in guinea pig and human
vagal afferents. These data are consistent with articles suggesting
that these channels are expressed in human peripheral sensory
nerves.42 Inhibition by theophylline of the calcium and voltage sig-
nals to the tussive agent was not preceded by an increase in [Ca21]i
levels, indicating that the concentrations of theophylline used did
not modify basal [Ca21]i levels in isolated sensory neurons.
To investigate this in more detail, we used a perforated patch
clamp system to preserve all intracellular content while prevent-
ing calcium influx, which would change basal [Ca21]i levels
through calcium-induced calcium release. Our electrophysiolog-
ical data indicated that theophylline activates guinea pig IK and
apamin-sensitive SK channels at resting [Ca21]i levels to inhibit
the depolarization of jugular neurons and are consistent with
data from Schroder et al43 demonstrating that methylxanthines
activate potassium channels without an increase in [Ca21]i levels.
Although the activation was not secondary to an increase in
[Ca21]i levels, single-channel recording suggested a requirement
for calcium to be present. The reduced activation of the IK channel
in comparison with the SK channel and the absence of an effect on
the BKCa channel could be linked to the different calcium
sensitivity and voltage dependence of these channels. Indeed,
IK channel open probability is poorly dependent on voltage and
is largely regulated by [Ca21]i. Its opening concentration
threshold can vary over a range of concentrations depending on
the conditions but remains higher than for SK. The BKCa channel
open probability is voltage dependent and requires high [Ca21]i
levels, suggesting that theophylline’s effect at the concentration
used was not enough to enhance activation of the BKCa channel
by [Ca21]i levels.
44,45 On the other hand, the SK channel is highly
sensitive to calcium and voltage insensitive. This gives it theability to open at low [Ca21]i levels independent from the
membrane potential, and it has been shown to be important in
controlling neuronal excitability and firing rate along axons.46
The wide range of calcium sensitivity for IK channel gating and
the need for high depolarization/increase in [Ca21]i levels to
open BKCa suggests that the resting [Ca
21]i levels under these
conditions would not be sufficient for theophylline to open these
channels. Theophylline binding to the SK channel could either
directly modify the open probability independently from the
gating or increase the binding of calcium, thereby acting as cal-
cium sensitizer. However, the possible activation of the IK chan-
nel, BK channel, or both by theophylline, when sensory neurons
are activated, [Ca21]i levels are increased, and the membrane is
depolarized, also remains a possibility. As mentioned previously,
an in vivo inhibitory effect of theophylline on PDE4 activity
cannot be completely ruled outwith regard to its invivo antitussive
activity, and in fact, protein kinase A activation has been shown to
indirectly activate the SK channel through an increase in [Ca21]i
levels.47 However, although protein kinase A regulates IK chan-
nels in oocytes,48 this is not apparent in mammalian cells.43,49
Therefore the possibility exists that the effect of theophylline on
SK channels could be mediated indirectly through an inhibition
of PDE activity.
Recently, ion channels of the TRP class, such as TRPV1, have
been implicated in the heightened cough sensitivity seen in
disease, and several studies have demonstrated an increase in
cough reflex sensitivity to capsaicin challenge in patients with
COPD.50,51 These datamight indicate that TRPV1 channels could
be key effectors of tussive responses in this disease and that these
channels could be associated with long-term potentiation of the
cough reflex. Capsaicin-induced tussive responses are also
increased in our conscious guinea pig model after cigarette smoke
exposure, modeling the human pathophysiology. The ability of
theophylline to decrease this exaggerated tussive response
suggests that this therapeutic approach might be effective in the
treatment of cough associated with COPD.
In conclusion, the antitussive activity of theophylline under
normal and disease conditions highlights a previously unrecog-
nized beneficial property of theophylline, and the discovery of its
mechanism of action might lead to the development of optimized
compounds with a reduced side effect potential.
Key messages
d Clinical studies have suggested that theophylline acts as
an antitussive agent in a range of conditions; however,
the mechanism of action is not known.
d Here we show that theophylline inhibits sensory nerve
activation (human and guinea pig) to a range of tussive
stimuli through increasing the open probability of
calcium-activated potassium channels (predominantly
the SK channel).
d These findings could highlight a previously unrecognized
beneficial property of theophylline and lead to the
development of optimized antitussive compounds.
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